Cargando…
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma
BACKGROUND: The targeted therapy for lung cancer relies on prognostic genes and requires further research. No research has been conducted to determine the effect of endothelin-converting enzyme 2 (ECE2) in lung cancer. METHODS: We analyzed the expression of ECE2 in lung adenocarcinoma (LUAD) and nor...
Autores principales: | Zhang, Yao-Hua, Zeng, Jing, Liu, Xu-Sheng, Gao, Yan, Kui, Xue-Yan, Liu, Xiao-Yu, Zhang, Yu, Pei, Zhi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588963/ https://www.ncbi.nlm.nih.gov/pubmed/36299451 http://dx.doi.org/10.3389/fendo.2022.1013238 |
Ejemplares similares
-
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021) -
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021) -
SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA
por: Liu, Xu-Sheng, et al.
Publicado: (2022) -
Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma
por: Liu, Xu-Sheng, et al.
Publicado: (2021) -
Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction
por: Zhang, Yong, et al.
Publicado: (2023)